ABSTRACT We have purified the epidermal growth factor (EGF) receptor/protein kdnase from the livers of normal mice by affinity chromatography. The biochemical properties of the liver receptor are very similar to those of the EGF receptor previously prepared from the human tumor cell line A-431 
Epidermal growth factor (EGF), a mitogenic polypeptide hormone, interacts with plasma membrane receptors in target cells to initiate and maintain a complex program of bioehemical and morphological events leading to cell growth and multiplication (1) . We have reported the purification of the receptor for EGF from plasma-membranes of A-431 cells, a human epidermoid carcinoma cell line. The receptor is a Mr 170,000 glycoprotein; it is copurified with an EGF-stimulable protein kinase activity that is specific for tyrosine residues (2, 3). We have suggested that the EGF-stimulable protein kinase activity and the EGF binding activity reside in two domains ofthe same molecule on the basis of affinity labeling (4) . The EGF receptor/kinase possesses "autophosphorylation" activity as well as kinase activity toward some exogenous proteins (2) and polypeptides (5) .
In this report we describe a two-step procedure involving EGF-affinity chromatography and immobilized lectin chromatography for the purification of the EGF receptor/protein kinase system from normal mouse liver and we document some of this system's biochemical properties.
MATERIALS AND METHODS Materials. Murine EGF was isolated (6) and iodinated (7) by published procedures. [y-32P]ATP was purchased from ICN.
Tubulin was a gift from W. Radany (Vanderbilt University). Rabbit serum from Rous sarcoma-bearing animals was a gift from T. Hunter (Salk Institute). The EGF receptor from A-431 cells and antiserum to the Mr 170,000 receptor protein from these cells were prepared as described (2) . Wheat germ lectinSepharose 6MB and N,N',N"-triacetylchitotriose were obtained from Sigma. Staphylococcal protein A-Sepharose CL-4B was obtained from Pharmacia. Tissues were liver, kidney, and brain from adult male Swiss Webster mice and human placenta.
EGF-Affi-Gel was prepared as follows: Affi-Gel 10 (a N-hydroxysuccinimide ester-of a succinylated aminoalkyl Bio-Gel A support, obtained from Bio-Rad) was allowed to react with EGF under anhydrous conditions. Sixty milligrams of EGF was dissolved in 2.25. ml of dimethyl sulfoxide (Pierce Chemical) containing 8.3 A.l of triethylamine. The Affi-Gel was washed on a sintered glass filter with 3 vol of dimethyl sulfoxide, and 3.6 g ofthe washed gel cake was added to the above solution ofEGF. The mixture was gently stirred for 4 hr at room temperature. The reaction was quenched by the addition of 6 /ul of ethanolamine and stirred for 2 hr at room temperature. The mixture was diluted with water and the gel was washed extensively, using successively 2 liters of water, 1 liter each of 1 M NaCl, 0.1 M acetic acid, and 1 M urea, 2 liters of water, and finally, 1 liter of 20 mM Hepes buffer, pH 7.4. The extent of coupling (approximately 70%) was determined by measuring the decrease in absorbance of EGF at 280 nm in 0.1 M HC1.
Standard Assays for Binding of "MI-Labeled EGF (125I-EGF). Binding of 125I-EGF to the particulate material in unfractionated homogenates was assayed by using the procedure described for A-431 membranes (8) . Binding of 125I-EGF to.Triton X-100-solubilized fractions. was assayed by a polyethylene glycol procedure (9) with two modifications: binding was carried. out in the presence of 0.5% bovine serum albumin and polyethylene glycol 8000 was used to precipitate the 125I-EGFreceptor complex.
Other Methods. The phosphorylation reaction was carried out exactly as described (9) . The procedures for gel electrophoresis (9% acrylamide), Coomassie blue staining, and autoradiography have been published (9) . The protein content of Triton-containing fractions was determined with bovine albumin as a standard (2) . The procedures for the partial acid hydrolysis of3P-containing proteins and subsequent electrophoretic separation of phospho amino acids have been described (3) . Procedures have been reported (2) for the covalent attachment of '"I-EGF to receptor preparations and for the precipitation of the EGF receptor/kinase by antiserum to the Mr 170,000 receptor by using protein A-Sepharose. The precipitation of IgG by protein A-Sepharose was carried out by a published procedure (10) .
RESULTS
Binding of I251-EGF in Crude Homogenates of A-431 Cells and Normal Tissue. In preliminary experiments we examined the ability of the particulate material in unfractionated homogenates of normal tissue and A-431 cells to bind '25I-EGF. The specific binding activity of homogenates of A-431 cells is approximately 10-fold higher than that of homogenates of mouse liver or of human placenta and approximately 50-to 100-fold higher than that of mouse kidney or brain (Table 1) . These data are in agreement with previously published reports that membrane fractions of liver and placenta were rich in receptor for Abbreviation: EGF, epidermal growth factor.
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Solubilization and Detection of the EGF Receptor/Protein Kinase in Normal Tissue by Affinity Chromatography. We have reported that membranes prepared from A-431 cells may be solubilized by using Triton X-100 with retention of much (over 60%) of-the capacity to bind 125I-EGF and with retention of EGF-stimulable kinase activity (9, 14) . However, it has been reported that the EGF receptor from liver or placenta loses its ligand recognition property after solubilization with detergents (15) when assayed by the polyethylene glycol precipitation method. We have, in general, confirmed these results: only 4-8% of the specific binding capacity of mouse liver or human placental homogenates was retained when Triton X-100 was added to the homogenates and binding was examined by the polyethylene glycol precipitation procedure (data not shown). The solubilization of placental or liver membranes with detergents does not appear to irreversibly inactivate the binding capability for 125I-EGF because immobilization of the solubilized receptor on lectin-agarose beads restores, at least partially, ligand recognition properties (15) .
In view of the efficacy with which EGF-Affi-Gel beads specifically adsorb the detergent-solubilized EGF receptor/kinase prepared from A-431 cells, we examined .the ability of EGF-Affi-Gel to adsorb kinase activity from Triton X-100-solubilized homogenates of mouse liver, kidney, and brain and human placenta. These preliminary experiments were carried out by passing 1 ml of Triton-containing extracts ofnormal tissue through 50-,ul columns ofEGF-Affi-Gel. The gels were washed with 3 ml of buffer (containing 0.2% Triton), and the gel cake with adsorbed material was used' as an enzyme/substrate mixture in a kinase assay. The tissue extracts were prepared by homogenizing 1 g of tissue with 5 ml of 20 mM Hepes buffer, pH 7.4, containing glycerol (10%; vol/vol), Triton X-100 (5%, vol/vol), and MgCl2 (2 mM).. The homogenates were centrifuged at 40,000 rpm in. a type 42.1 Beckman rotor for 1 hr at 40C to remove insoluble material.
In the above experiments we examined (i, the composition of the material adsorbed to the EGF-Affi-Gel (by NaDodSO4 gel electrophoresis and Coomassie blue staining), and (ii) the components phosphorylated in the presence of [ y-32P]ATP(by NaDodSO4 gel electrophoresis and autoradiography). We conclude from the Coomassie blue staining data ( Fig. 1, lanes A-D) that a substantial number of diverse proteins from each tissue (liver, brain, kidney, placenta) remain adsorbed to the EGFAffi-Gel under these conditions. We conclude from the phosphorylation data (Fig. 1 tracts of liver were phosphorylated and examined as illustrated in Fig. 1 , only a trace of an EGF-stimulted phosphorylation of a Mr 170,000 component was noted (data not shown).
The specificity of the EGF-Affi-Gel for the adsorption of protein kinase from liver extracts was-examined in an analogous experiment using insulin-Affi-Gel. Although many proteins were adsorbed to the gel, no 32P-labeled proteins (other than some aggregated material) were detectable when the gel was phosphorylated under conditions identical to those used in Fig.  1 (data not shown) .
The protein kinase activity that was adsorbed to the gel from the detergent extracts of liver was derived from particulate (presumably membranous) components of the liver cell, as indicated by the result of the following experiment. Liver homogenates were prepared in the absence of Triton and centrifuged at 100,000 x g for 1 hr. The supernatant fluid and the pellet were adjusted to 5% Triton X-100 and aliquots were passed through EGF-Affi-Gel columns and phosphorylated as in Fig. 1 . A P-labeled Mr 170,000 component was detected in. the Triton-solubilized pellet; no phosphorylation was detected in the supernatant fraction (data not shown).
EGF-Affinity Purification of the EGF Receptor/Kinase from Liver. The following recycling procedure was adopted for the adsorption of the receptor/kinase from liver extracts. The livers of adult male mice were excised. and 30 g, wet weight, was homogenized with 150 ml of the following-buffer: 20 mM Hepes, pH 7.4, containing Triton X-100 (5%, vol/vol), glycerol (10%, vol/vol), MgCl2 (2 mM), EGTA (1 'mM), and leupeptin .(final concentration 5 ,g/ml). The homogenization was carried out at 0C with a Brinkmann Polytron at a setting of 5 for 30 sec..The mixture was centrifuged for 1 hr at 40,000 rpm in a Beckman 42.1 rotor at 40C. The pellet was discarded and 140 ml of the supernate was passed through a column of EGF-AffiGel (1.9 X 1.7 cm) at 5YC with a flow rate of 1.5 ml per min. The effluent was recycled two times through the same column under identical conditions. Because many proteins are adsorbed to the EGF-Affi-Gel column (see Fig. 1, lane A) (Fig. 2, lane A) showed the presence of a Mr 170,000 protein as well as several other proteins of both higher and lower molecular weight. Similar results were obtained when the EGF-Affi-Gel elution buffer contained EGF (2 mg/ml) in place of the ethanolamine, although some of the "contaminating" proteins were less evident. The use of EGF for elution, however, would preclude binding studies. (Fig. 2, lanes F and G) but did contain the bulk of the contaminating proteins (Fig. 2, lane B) . An identical pattern (as seen in Fig. 2, lane C) was seen when N-acetylglucosamine (300 mM) was used in the elution buffer in place ofthe acetylchitotriose. The Mr 170,000 and Mr 150,000 components were observed in all preparations, whereas the Mr 45,000 component was present in most, but not all, preparations.
The experiment depicted in Fig. 2, lanes C, H, Fig. 3 that, after 8 preparation from liver is shown in Fig. 4 . The dissociation constant (Kd) was calculated to be 1.58 X 10-8 M. This value is similar to that reported for the purified Mr 170,000 EGF receptor isolated from A-431 cells (2).
Covalent Binding of '"I-EGF to the Double Affinity-Purified Liver Receptor/Protein Kinase Preparation. The covalent attachment of 125I-EGF, prepared by the chloramine-T procedure, to putative membrane receptors by incubating 125i-EGF with cells, membranes, or purified receptors has been described (2, 16). The chemistry of this reaction is not understood. We have incubated the double affinity-purified preparation from liver with 125I-EGF and have examined the covalent attachment sites by autoradiography after NaDodSO4 gel electrophoresis. The results (Fig. 5, lane A) indicate that apparent covalent linkages occur between 125I-EGF and the Mr 170,000 and 150,000 components, although with the latter to a lesser extent. This labeling is specific [i.e., prevented by excess unlabeled EGF (Fig. 5, lane B) or by heating the receptor for 2 min at 1000C (Fig. 5, lane C) ]. These results suggest that the Mr 150,000 component as well as the Mr 170,000 component have binding sites for EGF. The amino acid specificity of the autophosphorylation reaction was examined by partial acid hydrolysis and electrophoresis of the 32P-labeled Mr 170,000 protein eluted from NaDodSO4 gels. Autoradiographs ofthe electropherograms (Fig. 6) showed the presence of phosphotyrosine; no phosphoserine or phosphothreonine was detectable.
We have reported previously that the receptor/kinase preparation from A-431 cells is able to specifically phosphorylate, in vitro, certain added proteins, such as tubulin and rabbit antibodies directed against pp6src present in sera from Rous sarcoma-bearing animals (10) . The data (Fig. 7) show that the mouse liver preparations are also capable of phosphorylating these substrates, although it was not possible to detect an appreciable stimulation of the reaction by the addition of EGF.
Finally, we have examined whether rabbit antibodies directed against the NaDodSO4-gel purified Mr 170,000 EGF receptor/kinase derived from A-431 cells crossreact with the receptor derived from mouse liver. It may be seen in Fig. 8 Fig. 2 ) represents an artifactual degradation product or is a normal component in liver is not known. In this connection, an EGF-stimulated phosphorylation of a Mr 120,000 protein in mouse liver membranes has been noted (17) .
With regard to the EGF receptor/protein kinase in other cell types and in normal tissue, an EGF-enhanced phosphorylation of a Mr 170,000 protein has been detected in membrane preparations derived from human fibroblasts (18) , NRK cells (19) , human placenta (12) , and rat liver (20) . The data suggest that the EGF receptor will be found to be an evolutionarily conserved molecule and that one of the functions of the receptor in all cells is the phosphorylation of specific proteins at tyrosine residues.
